Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
2005-04-19
2005-04-19
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
Reexamination Certificate
active
06881751
ABSTRACT:
The present invention relates to a pharmaceutical preparation containing at least one compound of general formula (I)wherein R1and R2are each independently of each other a straight-chain or branched alkyl residue having 1 to 30 carbon atoms, a straight-chain or branched alkenyl residue having 2 to 30 carbon atoms, a monocyclic or polycyclic alkyl residue having 3 to 30 carbon atoms, a monocyclic or polycyclic alkenyl residue having 4 to 30 carbon atoms, or a monocyclic or polycyclic aromatic residue having 6 to 30 carbon atoms, these residues being optionally substituted by one or several substituents. This invention also relates to the use of the pharmaceutical preparations for the immunosuppressive treatment and for the non-invasive treatment.
REFERENCES:
patent: 4843161 (1989-06-01), Lippard et al.
patent: 4885376 (1989-12-01), Verkade
patent: 5068375 (1991-11-01), Singhal
patent: 5844001 (1998-12-01), McClay et al.
patent: 0163316 (1985-04-01), None
patent: WO 9418990 (1994-09-01), None
CA107:108004, Osa T et al, Chemical & Pharmaceutical Bulletin, 1986, 34(9) 3563-72, abstract.*
Medline AN 90112359, Hollis L et al, J. Medicinal Chem, 1990 Jan., 33(1) 105-11, abstract.*
Medline AN 96354887, Shibusawa M et al, Cancer & Chemo., 1996 Aug., 23(9) 1149-52, abstract.*
Medline AN 1998252553, Weisman R et al, Otolaryg.-head and neck surgery, 1998 May, 118(5) 597-602, abstract.*
Medline AN 1998277308, Tessier M et al, Annales de dermatologie et de venereologie, 1996, 123 (9) 538-42, abstract.*
Fackler, J.P., et al., “Five-Coordinate Complexes of Platinum (II) and Palladium (II)”, J. Am. Chem. Soc., (1968), 90(10), 2702-9.
Cornock, Margaret C. , et al., “Metal Complexes of Sulphur Ligands. Part 11. Reactions of Platinum (II) and Palladium (II) Dithiocarbonates with Dithiocarbonate Ions”, J. Chem. Soc., Salton Trans., (1977), (5), 496-501.
Osa, Tetsuo, et al. “Synthesis and anti tumor activity of cis-dish dichloroplatinum complexes coordinating nitrogen cyclic or sulfur compounds” Chem. Pharm. Bull. (1989), 34(9), 3563-72.
Marcheselli, L., et al., “Synthesis, characterization and evaluation of bological activity of palladium (II) and platinum (II) complexes with dithiocarbamic acids and their derivatives as ligands” Eur. J. Med. Chem. (1993), 28 (4), 347-52; and.
Sindellari, L. Et. Al, “Dithiocarbamates as antagonists of cisplatin toxicity” Inorg. Chim. Acta (1987) 137 (1-2), 109-13; and.
Mitchell, Kathryn, et al., “Isolation, Reactivity, and Molecular Structure of Pt2 u-L-SCH2 CH(COO)NHC(O)CH3-S2(bpy)2: Model of the Interaction of Platinum with Protein Sulfur Residues”, Inorg. Chem. 1993, 32, 2608-2609.
Original and English Translation of: Craciunescu, D.G., et al, “Dual in vivo pharmacological activities (antitrypanosomal and antitumor) of some new complexes of platnium (II) and platinum (IV)”, An. R. Acad. Farm. (1992), 58 (4), 529-49.
Kharkyevitch, D. A., (1987),The dependence of the pharmacotherapeutic effect on the properties of pharmaceuticals and on their application conditions. Medicine (Moscow) pp. 47-48 [English Translation of original Russian article].
Amtmann Eberhard
Schilling Gerhard
Cook Rebecca
Palmer & Dodge LLP
Ruprecht Karls Universitat
Williams Kathleen M.
LandOfFree
Medicament containing platinum complex compounds and the use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament containing platinum complex compounds and the use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament containing platinum complex compounds and the use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3371652